salicylic acid 3% sulfur 3% ointment
extemp order - sulfur precipitated; salicylic acid; magnesium sulfate dried; phenoxyethanol; wool alcohols ointment - ointment - 3mg/1gram ; 3mg/1gram ; 5mg/1gram ; 10mg/1gram ; 500mg/1gram
cortival 1/2 betamethasone 0.5mg/g (as valerate) ointment tube
aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.
betnovate 1/2 betamethasone 0.5mg/g (as valerate) ointment tube
aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 0.61 mg/g (equivalent: betamethasone, qty 0.5 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.
betnovate betamethasone 1mg/g (as valerate) ointment tube
aspen pharmacare australia pty ltd - betamethasone valerate, quantity: 1.22 mg/g (equivalent: betamethasone, qty 1 mg/g) - ointment - excipient ingredients: liquid paraffin; white soft paraffin - indications as at 23 april 2004 : eczema including : atopic, infantile, stasis and discoid eczemas. besnier's (flexural) prurigo. otitis externa. neurodermatoses including lichen simplex, lichen planus. seborrheic dermatitis, contact sensitivity reactions and allergies.
salicylic acid 3% sulfur 3% ointment
special order - sulfur precipitated; salicylic acid; magnesium sulfate dried; phenoxyethanol; wool alcohols ointment - ointment - 3mg/1gram ; 3mg/1gram ; 5mg/1gram ; 10mg/1gram ; 500mg/1gram
salicylic acid 2% ointment
ennogen healthcare ltd - salicylic acid; wool alcohols ointment - ointment - 20mg/1gram ; 980mg/1gram
egoderm ointment tube
ego pharmaceuticals pty ltd - zinc oxide, quantity: 150 mg/g; ichthammol, quantity: 10 mg/g - ointment - excipient ingredients: light liquid paraffin; propyl hydroxybenzoate; isopropyl myristate; dimeticone 350; methyl hydroxybenzoate; glyceryl monostearate; glycerol; polyethylene; purified talc; white soft paraffin - for the temporary relief of irritation of tender, itchy, scratched or broken skin rashes, dermatitis, genital or anal irritation, minor cold sores, napkin rash and the symptoms of eczema. an alternative to cortisone ointments for sub-acute skin eruptions.
medicianz mupirocin nasal ointment mupirocin (as calcium) 20 mg/g (2% w/w) ointment tube
medsurge pharma pty ltd - mupirocin calcium, quantity: 21.5 mg/g (equivalent: mupirocin, qty 20 mg/g) - ointment - excipient ingredients: white soft paraffin; bis-diglyceryl polyacyladipate-2 - medicianz mupirocin nasal ointment is indicated for the elimination of nasal carriage of staphylococci, including methicillin resistant staphylococcus aureus (mrsa).
betadine cold sore ointment povidone-iodine 100mg/ml tube
sanofi-aventis healthcare pty ltd t/a sanofi consumer healthcare - povidone-iodine, quantity: 10 % w/w (equivalent: iodine, qty 10 mg/g) - ointment - excipient ingredients: macrogol 400; macrogol 3350; sodium bicarbonate; purified water; macrogol 1500; macrogol 1000 - for the treatment of cold sores. betadine cold sore ointment, if applied at the first signs of a cold sore (usually itching or tingling sensation) can help to check the infection. they can inactivate the virus, thus reducing the risk of spread of infection.
mometasone medis mometasone furoate 0.1% w/w ointment tube
medis pharma pty ltd - mometasone furoate, quantity: 1 mg/g - ointment - excipient ingredients: hexylene glycol; white soft paraffin; white beeswax; propylene glycol monostearate - mometasone medis ointment is indicated for short-term (up to 4 continuous weeks) relief of inflammatory and pruritic manifestations of corticosteroid responsive dermatoses, such as psoriasis and atopic dermatitis.